Nitric oxide in streptozotocin-induced diabetes mellitus in rats

Clinical Science

Volumn 90, Issue 5, 1996, Pages 379-384

  Maree, Abed ^a   Peer, Gari ^a   Iaina, Adrian ^a   Blum, Miriam ^a   Wollman, Yoram ^a   Csernihovsky, Tamara ^a   Silverberg, Donald S ^a   Cabili, Shaltiel ^a  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Diabetes mellitus; L arginine; Nitrate; Nitric oxide; Nitric oxide synthase inhibitor; Nitrite; Streptozotocin

Indexed keywords

ARGININE; GLUCOSE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; SYSTOLIC BLOOD PRESSURE; ULTRAFILTRATION; URINARY EXCRETION; URINE LEVEL;

EID: 0029970382     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0900379     Document Type: Article

References (35)

1. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981; 19: 410-15.
2. Christiansen JS, Gammelgaard J, Frandsen M, Parving HH. Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin dependent diabetes. Diabetologia 1981; 20: 451-6.
3. Hostetter TH. Pathogenesis of diabetic glomerulopathy: hemodynamic considerations. Semin Nephrol 1990; 10: 219-27.
4. Bank N. Mechanism of diabetic hyperfiltration. Kidney Int 1991; 40: 792-807.
5. Bank N, Aynedjian HS. Role of EDRF (nitric oxide) in diabetic renal hyperfiltration. Kidney Int 1993; 43: 1306-12.
6. Reyes AA, Karl IE, Kissane J, Klahr S. L-Arginine administration prevents glomerular hyperfiltration and decreases proteinuria in diabetic rats. J Am Soc Nephrol 1993; 4: 1039-45.
7. Tollins JP, Shultz PJ, Raij L, Brown DM, Mauer SM. Abnormal renal hemodynamic response to reduced renal perfusion pressure in diabetic rats: role of NO. Am J Physiol 1993; 265: F886-95.
8. Komers R, Allen TJ, Cooper ME. Role of endothelium-derived nitric oxide in the pathogenesis of the renal hemodynamic changes of experimental diabetes. Diabetes 1994; 43: 1190-7.
9. Kamata K, Miyato N, Kasnya Y. Impairment of endothelium dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin induced diabetic rats. Br J Pharmacol 1989; 97: 614-18.
10. Craven PA, Studer RK, De Rubertic FR. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 1994; 93: 311-20.
11. Schwartz D, Blum M, Peer G et al. Role of nitric oxide in radiocontrast acute renal failure in rats. Am J Physiol 1994; 267: F374-9.
12. Moshage H, Kok B, Huizenga JR, Janse PLM. Nitrite and nitrate determinations in plasma: a clinical evaluation. Clin Chem 1995; 61: 892-6.
13. Greenberg SS, Xie JM, Spitzer JJ et al. Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite. Life Sci 1995; 57: 1949-61.
14. Vallance P, Collier J, Moncada S. Effects of endothelial-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1989; ii: 997-1000.
15. De Belder AJ, Radomsky MW. Nitric oxide in the clinical arena. J Hypertens 1994; 12: 617-24.
16. Suto T, Losonczy G, Qiu C et al. Acute changes in urinary nitrite+nitrate do not necessarily predict renal vascular NO production. Kidney Int 1995; 48: 1272-7.
17. Reaven RE. Insulin resistance and compensatory hyperinsulinemia: role in hypertension, dyslipidemia and coronary heart disease. Am Heart J 1991; 121: 1283-8.
18. Barbagallo M, Resnick LM. The role of glucose in diabetic hypertension: effects on intracellular cation metabolism. Am J Med Sci 1994; 307: S60-5.
19. Weisbrod RM, Brown ML, Cohen RA. Effects of elevated glucose on cyclic GMP and eicosanoids produced by porcine aortic endothelium. Arterioscler Thrombosis 1993; 131: 915-23.
20. Ohishi K, Okwueze MI, Vari RC, Carmines PK. Juxtamedullary microvascular dysfunction during the hyperfiltration stage of diabetes mellitus. Am J Physiol 1994; 267: F99-105.
21. Diederich D, Skepec J, Diederich A, Dai FX. Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: role of free radicals. Am J Physiol 1994; 266: H1153-61.
22. Ohishi K, Carmines PK. Superoxide dismutase restores the influence of nitric oxide on renal arterioles in diabetes mellitus. J Am Soc Nephrol 1995; 5: 1559-66.
23. Marcus RG, England R, Nguyen K, Charron MJ, Briggs JP, Brosius FC, 3rd. Altered renal expression of the insulin-responsive glucose transporter GLUT4 in experimental diabetes mellitus. Am J Physiol 1994; 267: F816-24.
24. Assreuy J, Cunha FQ, Liew FY, Moncada S. Feedback inhibition of nitric oxide synthase activity by nitric oxide. Br J Pharmacol 1993; 108: 833-7.
25. Buga GM, Griscavage JM, Rogers NE, Ignarro LJ. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res 1993; 73: 808-12.
26. Rogers NE, Ignarro LJ. Constitutive nitric oxide synthase from cerebellum is reversibly inhibited by nitric oxide formed from L-arginine. Biochem Biophys Res Commun 992; 189: 242-9.
27. Kiff RJ, Moss DW, Moncada S. Effect of nitric oxide gas on the generation of nitric oxide by isolated blood vessels: implications for inhalation therapy. Br J Pharmacol 1994; 113: 496-8.
28. Jorens PG, Matthys KE, Bult H. Modulation of nitric oxide synthase activity in macrophages. Mediators Inflammation 1995; 4: 75-89.
29. Takenaka T, Harrison-Bernard LM, Inscho EW, Carmines PK, Navar LG. Autoregulation of afferent arteriolar blood flow in juxtamedullary nephrons. Am J Physiol 1994; 267: F879-87.
30. Napathorn S, Chaiyabutr N, Buranakarl C et al. Effects of acute arginine loading on renal and systemic hemodynamics in dogs. Nephron 1992; 60: 220-5.
31. Kanno K, Hirata Y, Emori T et al. L-Arginine infusion induces hypotension and diuresis/natriuresis with concomitant increased urinary excretion of nitrite/nitrate and cyclic GMP in humans. Clin Exp Pharmacol Physiol 1992; 19: 619-25.
32. Ebel M, Catapano G, Colombo MG et al. The humoral, renal and pressor effects of systemic L-arginine infusion in hypertensive patients. J Hypertens 1993; 11: S140-1.
33. Schmidt HHHW, Warner TD, Ishu K, Sheng H, Murad F. Insulin secretion from pancreatic β cells caused by L-arginine-derived nitrogen oxides. Science (Washington, DC) 1992; 255: 721-3.
34. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90: 278-81.
35. Ribeiro MO, Antunes E, De Nucci G. Chronic inhibition of nitric oxide synthesis. A new model of hypertension. Hypertension 1992; 20: 298-303.